An astute position to take Kempeman.
Oscar, the caution that many are suggesting is because you very likely haven't seen the last capital raising, that's what i mean by they need for more cash. It's a great story, i totally agree but why buy or average down when at least one more discounted dilution is coming? It's just throwing money away.
The 304 million units are the most likely raising....So at what price?
- Forums
- ASX - By Stock
- SAS
- Today's Performance
Today's Performance, page-184
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SAS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online